Is this your company? Get featured or correct your listing →
Recent changes
- Jun 26, 2026Jun 26, 2026Raised $190M Series B Crunchbase News
- Jun 26, 2026Jun 26, 2026Osanni Bio Lands $190M Series B to Advance Its Therapeutics Platform Pulse story
Funding History
1 event · sources dated per row| Date | Event | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| Jun 26, 2026 | Series B | $190M | — | Pulse story |
Latest Pulse
- Jun 26, 2026Osanni Bio Lands $190M Series B to Advance Its Therapeutics PlatformOsanni Bio raised a $190 million Series B led by Patient Square Capital to push its therapeutics platform deeper into clinical development. The large biotech round underscores that 2026's reopening capital markets are not an AI-only story -- life sciences is once again drawing big checks and, increasingly, big exits.→
- Jun 26, 2026Ollin Biosciences Raises $330M Series B to Advance Its Therapeutics PipelineOllin Biosciences raised a $330 million Series B co-led by TCG Crossover and Arch Venture Partners, one of the largest life-sciences rounds of the week. The financing pushes its therapeutics pipeline deeper into clinical development and adds to mounting evidence that biotech's capital markets have reopened in force alongside the AI boom.→
Coverage Timeline
newest firstAll Coverage
Related Companies
Sources & methodologyshow
Where these figures come from
- Crunchbase Newsresearch database1 fact
Figures are labelled Reported (a source states it), Estimated, Derived (computed from other facts) or Rumored (in talks / unconfirmed). Rumors never replace a confirmed figure. Each figure keeps its own as-of date; history is preserved rather than overwritten.